Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.

Arend RB, Peroni BZ, Lima NL, Cruz Garcia M, Koerich AH, do Nascimento AF, Dos Santos RTF, Tapia K, Kerpel D, Jung GS, Roman A, Gago G, da Silva MBC, Vial ADM, Agosti E

Open source

DOI
10.3390/jpm16090479
Published
2026 Sep 17
Container
Journal of personalized medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jpm16090479,
  title = {Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.},
  author = {Arend RB and Peroni BZ and Lima NL and Cruz Garcia M and Koerich AH and do Nascimento AF and Dos Santos RTF and Tapia K and Kerpel D and Jung GS and Roman A and Gago G and da Silva MBC and Vial ADM and Agosti E},
  year = {2026},
  journal = {Journal of personalized medicine},
  doi = {10.3390/jpm16090479},
  url = {https://doi.org/10.3390/jpm16090479}
}

RIS

TY  - JOUR
TI  - Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.
AU  - Arend RB
AU  - Peroni BZ
AU  - Lima NL
AU  - Cruz Garcia M
AU  - Koerich AH
AU  - do Nascimento AF
AU  - Dos Santos RTF
AU  - Tapia K
AU  - Kerpel D
AU  - Jung GS
AU  - Roman A
AU  - Gago G
AU  - da Silva MBC
AU  - Vial ADM
AU  - Agosti E
PY  - 2026
JO  - Journal of personalized medicine
DO  - 10.3390/jpm16090479
UR  - https://doi.org/10.3390/jpm16090479
ER  - 

APA

RB, A., BZ, P., NL, L., M, C. G., AH, K., AF, D. N., RTF, D. S., K, T., D, K., GS, J., A, R., G, G., MBC, D. S., ADM, V., & E, A. (2026). Immunotherapy for Newly Diagnosed Glioblastoma: Current Evidence and Future Perspectives.. Journal of personalized medicine. https://doi.org/10.3390/jpm16090479

Source records